New research suggests that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who end traditional lifestyle plans.
Published data in a leading health publication demonstrates that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs need to be aware of the danger of quick weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
Such speed of regain means a reversion to original mass in about a year and a half.
Comparing Approaches
The research, which looked at 37 of studies involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.
The team emphasize that individuals who shed pounds through diet and exercise generally experience a less rapid creep back—approximately 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Nutrition scientists propose the mechanism of the drugs explains the heightened weight return.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone levels far above than normal may cause the system to produce less of its own natural hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement means hunger is unsuppressed, making excessive eating much more probable."
An Ongoing Issue?
The NHS recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians say that, given the high risk of relapse, the therapy is often life-long.
This opinion is reinforced by pharmaceutical companies, who note that the findings "emphasize the persistent nature of obesity," akin to managing conditions like hypertension.
Patient Testimonies
Individuals who have come off the medication explain a sudden resurgence of appetite.
"I experienced a trigger flipping and I was suddenly ravenous," recalled a patient.
This difficulty is compounded if users have not developed lasting dietary or behavioural modifications during therapy.
Widespread Interest
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is more common among females compared to men.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers caution that while the jabs are powerful tools for weight loss, they are not a magic cure and long-term success relies on integrated behavioural changes.
